XML 21 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Common Stock and Stockholders' Equity (Tables)
 6 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Schedule of Stock Option and RSU Award Activities
The following table summarizes the Company’s stock option and RSU award activities for the six months ended September 30, 2019 (in thousands, except exercise price, contractual term and fair value information):
 Options OutstandingRSUs Outstanding
 Number
of Shares		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term
(in years)		Aggregate Intrinsic ValueNumber
of Shares		Weighted-
Average
Grant Date
Fair Value		Weighted-
Average
Remaining
Contractual
Term
(in years)		Aggregate Intrinsic Value
Outstanding - April 1, 20192,751  $35.10  6.3$176,002  2,419  $76.34  3.0$238,734  
Stock options granted273  91.94  
RSUs granted521  82.25  
Stock options exercised(121) 25.22  7,872  
RSUs vested(432) 61.85  
Stock options canceled/forfeited(43) 67.87  
RSUs canceled/forfeited(212) 75.54  
Outstanding - September 30, 20192,860  $40.45  5.6$85,051  2,296  $80.48  2.7$141,140  
Schedule of Stock-based Compensation Expense Attributed to Cost of Revenue, Research and Development, Sales and Marketing and General and Administrative Expenses Cost of revenue, research and development, sales and marketing, and general and administrative expenses were as follows (in thousands):
 Three Months Ended September 30,Six Months Ended September 30,
 2019201820192018
Cost of revenue$1,300  $895  $2,522  $1,588  
Research and development7,434  3,858  14,462  7,121  
Sales and marketing10,533  6,028  19,592  10,818  
General and administrative4,091  3,052  7,970  5,333  
Total stock-based compensation expense$23,358  $13,833  $44,546  $24,860